ckat August 1, 2019, 7:27pm #1

Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031...

OLDWICK, N.J., April 9, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and...

2 Likes

Home
Categories
FAQ/Guidelines
Terms of Service
Privacy Policy

Powered by Discourse, best viewed with JavaScript enabled

FUDiabetes

Have hope here for newly diagnosed. What do u think?